It’s time to take stock on what temporary measures need to be made permanent to grow as an industry.
Companies within the life sciences industry should rethink how they manage their data and documents.
Understanding the cost to service by product and by subcomponent will help you identify which service events are the most impactful to the bottom-line financials of the business.
Contract profitability requires real-time visibility into assets so manufacturers can make decisions proactively rather than reactively and maintain customer excellence.
Medtech businesses show tremendous potential for profitability and growth, triggering a sparked interest in investment.
Anyone can read the regulation. The challenge is in how to apply it to your company’s structure and product line.
Software continues to be a key factor in recalls, and this year the end of some EUAs may also contribute to an increase.
In this series we examine the future of the medical device industry—from manufacturing to the consumer-patient experience.
Labeling is as critical as quality for medical device products. If a manufacturer can’t shift labeling to meet production in an agile manner, their products may not reach their destination.
We have the opportunity to refine processes that were implemented in a hurry during the pandemic, along with the insight to improve the entire healthcare system.